Sens. Charles Grassley (R-IA) and Amy Klobuchar (D-MN) on Thursday (Nov. 8) asked the president to endorse their bill to ban settlements between brand and generic drug makers that delay generic competition. The duo’s request takes on additional importance now that Democrats have retaken the House and the president has said he wants to work across party lines on drug pricing. Plus, Grassley is expected to seek the chairmanship of the Finance Committee, which has authority over Medicare drug price...